Screener
Dyne Therapeutics, Inc. DYN Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 125,276 | 122,372 |
| Loss from operations | (125,276) | (122,372) |
| Other income (expense): | ||
| Interest income | 8,757 | 7,100 |
| Interest expense | (4,202) | — |
| Other expense, net | (133) | (89) |
| Total other income, net | 4,422 | 7,011 |
| Net loss | $(120,854) | $(115,361) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s interest income?
- Dyne Therapeutics, Inc. (DYN) reported interest income of $8.76M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s interest income changed year-over-year?
- Dyne Therapeutics, Inc.'s interest income increased by 23.3% year-over-year, from $7.1M to $8.76M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s interest income has grown at a 151.9% compound annual growth rate (CAGR), from $742K to $29.86M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Dyne Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude